Cerebral venous sinus stenting in idiopathic intracranial hypertension

© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

Abstract

Cerebral venous sinus stenting (CVSS) is a minimally invasive procedure using endovascular stent placement to relieve elevated intracranial pressure secondary to venous sinus stenosis. Increased venous sinus pressure secondary to stenosis is commonly associated with elevated intracranial pressure without intracranial lesions on imaging or idiopathic intracranial hypertension (IIH). While the etiology of IIH remains unknown, stenosis of one or more of the dural sinuses has been implicated as a possible underlying mechanism. The manifestations of IIH include headaches, transient vision loss, pulsatile tinnitus, and neck pain. In this review, we discuss the recent studies that have demonstrated the effectiveness of CVSS for patients with IIH and also the indications, technical challenges, potential complications, and emerging developments in CVSS.

Keywords

Cerebral venous sinus stenting

Idiopathic intracranial hypertension

Pulsatile tinnitus

Venous sinus stenosis

Funding

None.

References

[1]

Bayot ML, Reddy V, Zabel MK, 2022, Neuroanatomy, dural venous sinuses. In: StatPearls. Treasure Island, FL: StatPearls Publishing.

[2]

Hufnagle JJ, Tadi P, 2022, Neuroanatomy, brain veins. In: StatPearls. Treasure Island, FL: StatPearls Publishing.

[3]

Puffer RC, Mustafa W, Lanzino G, 2013, Venous sinus stenting for idiopathic intracranial hypertension: A review of the literature. J Neurointerv Surg, 5: 483–486. https://doi.org/10.1136/neurintsurg-2012-010468

[4]

Daggubati LC, Liu KC, 2019, Intracranial venous sinus stenting: A review of idiopathic intracranial hypertension and expanding indications. Cureus, 11: e4008. https://doi.org/10.7759/cureus.4008

[5]

Kilgore KP, Lee MS, Leavitt JA, et al., 2017, Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology, 124: 697–700. https://doi.org/10.1016/j.ophtha.2017.01.006

[6]

Gaier ED, Heidary G, 2019, Pediatric idiopathic intracranial hypertension. Semin Neurol, 39: 704–710. https://doi.org/10.1055/s-0039-1698743

[7]

Sheldon CA, Paley GL, Beres SJ, et al., 2017, Pediatric pseudotumor cerebri syndrome: Diagnosis, classification, and underlying pathophysiology. Semin Pediatr Neurol, 24: 110. https://doi.org/10.1016/J.SPEN.2017.04.002

[8]

Gurney SP, Ramalingam S, Thomas A, et al., 2020, Exploring the current management idiopathic intracranial hypertension, and understanding the role of dural venous sinus stenting. Eye Brain, 12: 1–13. https://doi.org/10.2147/EB.S193027

[9]

Farb RI, Vanek I, Scott JN, et al., 2003, Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis. Neurology, 60: 1418–1424. https://doi.org/10.1212/01.wnl.0000066683.34093.e2

[10]

Ball AK, Clarke CE, 2006, Idiopathic intracranial hypertension. Lancet Neurol, 5: 433–442. https://doi.org/10.1016/S1474-4422(06)70442-2

[11]

Thurtell MJ, 2019, Idiopathic intracranial hypertension. Continuum (Minneap Minn), 25: 1289–1309. https://doi.org/10.1212/CON.0000000000000770

[12]

Shaw GY, Million SK, 2012, Benign intracranial hypertension: A diagnostic dilemma. Case Rep Otolaryngol, 2012: 814696. https://doi.org/10.1155/2012/814696

[13]

Friedman DI, Liu GT, Digre KB, 2013, Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology, 81: 1159–1165. https://doi.org/10.1212/wnl.0b013e3182a55f17

[14]

Tan MG, Worley B, Kim WB, et al., 2020, Drug-induced intracranial hypertension: A systematic review and critical assessment of drug-induced causes. Am J Clin Dermatol, 21: 163–172. https://doi.org/10.1007/S40257-019-00485-Z

[15]

Barkatullah AF, Leishangthem L, Moss HE, 2021, MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol, 34: 75–83. https://doi.org/10.1097/WCO.0000000000000885

[16]

Raman A, Uprety M, Calero MJ, et al., 2022, A systematic review comparing digital subtraction angiogram with magnetic resonance angiogram studies in demonstrating the angioarchitecture of cerebral arteriovenous malformations. Cureus, 14: e25803. https://doi.org/10.7759/cureus.25803

[17]

Teleb MS, Cziep ME, Lazzaro MA, et al., 2013, Idiopathic intracranial hypertension. A systematic analysis of transverse sinus stenting. Interv Neurol, 2: 132–143. https://doi.org/10.1159/000357503

[18]

The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, et al., 2014, Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: The idiopathic intracranial hypertension treatment trial. JAMA, 311: 1641–1651. https://doi.org/10.1001/jama.2014.3312

[19]

Bono F, Giliberto C, Mastrandrea C, et al., 2005, Transverse sinus stenoses persist after nor-malization of the CSF pressure in IIH. Neurology, 65: 1090–1093. https://doi.org/10.1212/01.wnl.0000178889.63571.e5

[20]

Kahan J, Sundararajan S, Brown K, et al., 2021, Predicting the need for retreatment in venous sinus stenting for idiopathic intracranial hypertension. J Neurointerv Surg, 13: 574–579. https://doi.org/10.1136/neurintsurg-2020-016550

[21]

Al-Mufti F, Dodson V, Amuluru K, et al., 2020, Neuroendovascular cerebral sinus stenting in idiopathic intracranial hypertension. Interv Neurol, 8: 164–171. https://doi.org/10.1159/000500051

[22]

Ahmed RM, Zmudzki F, Parker GD, et al., 2014, Transverse sinus stenting for pseudotumor cerebri: A cost comparison with CSF shunting. AJNR Am J Neuroradiol, 35: 952–958. https://doi.org/10.3174/ajnr.A3806

[23]

King JO, Mitchell PJ, Thomson KR, et al., 1995, Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology, 45: 2224–2228. https://doi.org/10.1212/wnl.45.12.2224

[24]

Higgins JN, Owler BK, Cousins C, et al., 2002, Venous sinus stenting for refractory benign intracranial hypertension. Lancet, 359: 228–230. https://doi.org/10.1016/S0140-6736(02)07440-8

[25]

Matloob SA, Toma AK, Thompson SD, et al., 2017, Effect of venous stenting on intracranial pressure in idiopathic intracranial hypertension. Acta Neurochir, 159: 1429–1437. https://doi.org/10.1007/s00701-017-3229-6

[26]

Leishangthem L, SirDeshpande P, Dua D, et al., 2019, Dural venous sinus stenting for idiopathic intracranial hypertension: An updated review. J Neuroradiol, 46: 148– 154. https://doi.org/10.1016/j.neurad.2018.09.001

[27]

Bai C, Chen Z, Wu X, et al., 2022, Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting. BMC Neurol, 22: 209. https://doi.org/10.1186/s12883-022-02731-0

[28]

Ramos AD, Sundararajan S, Santillan A, et al., 2020, Single arm access venous sinus stenting (SAVeS) technique: Technical note. Interv Neuroradiol, 26: 501–505. https://doi.org/10.1177/1591019920920992

[29]

Schwarz J, Santillan A, Patsalides A, 2020, Safely traversing venous sinus stenosis: The “Cobra” technique. Interv Neuroradiol, 26: 231. https://doi.org/10.1177/1591019919894802

[30]

Dalfino JC, Entezami P, Field NC, et al., 2021, Regarding safely traversing venous sinus stenosis: The ‘Cobra’ technique. Interv Neuroradiol, 28: 521–522. https://doi.org/10.1177/15910199211050533

[31]

Dossani RH, Waqas M, Tso MK, et al., 2021, Endovascular management of radial artery loop for neuroangiography: Case series. Interv Neuroradiol, 27: 566–570. https://doi.org/10.1177/1591019920982812

[32]

Merella P, Lorenzoni G, Casu G, 2019, Inside the “Razor Effect”: Lessons from optical coherence tomography-what does angiography hide? JACC Cardiovasc Interv, 12: 409–410. https://doi.org/10.1016/J.JCIN.2018.09.038

[33]

Wong SC, Desai S, Navigating Complex Radial Loops- Cardiac Interventions Today. Available from: https://www. citoday.com/articles/2019-jan-feb/navigating-complex-radial-loops [Last accessed on 2022 Nov 12].

[34]

Sinha SK, Mishra V, Jha MJ, et al., 2017, Primary percutaneous coronary intervention using balloon-assisted sliding and tracking (BLAST) of diagnostic catheter to negotiate double hairpin loop of radial artery. Cardiol Res, 8: 81–85. https://doi.org/10.14740/cr540w

[35]

Drocton GT, Copelan A, Eisenmenger L, et al., 2021, Venous sinus stenting as a treatment approach in patients with idiopathic intra-cranial hypertension and encephaloceles. Interv Neuroradiol, 27: 129–136. https://doi.org/10.1177/1591019920956860

[36]

Su H, Li B, Wang J, et al., 2019, Headache attributed to cranial venous sinus stenting: A case series and literature review. Cephalalgia, 39: 1277–1283. https://doi.org/10.1177/0333102419847752

[37]

Dinkin MJ, Patsalides A, 2017, Venous sinus stenting in idiopathic intracranial hypertension: Results of a prospective trial. J Neuroophthalmol, 37: 113–121. https://doi.org/10.1097/WNO.0000000000000426

[38]

Lakhani DA, Yuan F, Deib G, 2022, Photorealistic depiction of intracranial arteriovenous malformation using cinematic rendering of volumetric MRI data for presurgical planning and patient education. J Neurointerv Surg, 14: 311–312. https://doi.org/10.1136/neurintsurg-2021-018281

[39]

Raper DM, Ding D, Chen CJ, et al., 2017, Patency of the vein of Labbé after venous stenting of the transverse and sigmoid sinuses. J Neurointerv Surg, 9: 587–590. https://doi.org/10.1136/neurintsurg-2016-012903

[40]

Li K, Ren M, Meng R, et al., 2018, Dural arteriovenous fistula formation complicated cerebral venous sinus stenosis after venous sinus stenting. World Neurosurg, 120: 400–402. https://doi.org/10.1016/J.WNEU.2018.08.230

[41]

Sun WY, Switzer NJ, Dang JT, et al., 2020, Idiopathic intracranial hypertension and bariatric surgery: A systematic review. Can J Surg, 63: E123–E128. https://doi.org/10.1503/cjs.016616

[42]

Doble B, Wordsworth S, Rogers CA, et al., 2017, Erratum to: What are the real procedural costs of bariatric surgery? A systematic literature review of published cost analyses. Obes Surg, 27: 2193. https://doi.org/10.1007/s11695-017-2768-5

[43]

Aguiar M, Frew E, Mollan SP, et al., 2021, The health economic evaluation of bariatric surgery versus a community weight management intervention analysis from the idiopathic intracranial hypertension weight trial (IIH: WT). Life (Basel), 11: 409. https://doi.org/10.3390/life11050409

[44]

Lai LT, Danesh-Meyer HV, Kaye AH, 2014, Visual outcomes and headache following interventions for idiopathic intracranial hypertension. J Clin Neurosci, 21: 1670–1678. https://doi.org/10.1016/j.jocn.2014.02.025

[45]

Yiangou A, Mitchell J, Markey KA, et al., 2019, Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain? Cephalalgia, 39: 245–253. https://doi.org/10.1177/0333102418782192

[46]

Lavoie P, Audet MÈ, Gariepy JL, et al., 2018, Severe cerebellar hemorrhage following transverse sinus stenting for idiopathic intracranial hypertension. Interv Neuroradiol, 24: 100–105. https://doi.org/10.1177/1591019917734389

[47]

Jefferis JM, Littlewood RA, Pepper IM, et al., 2021, Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population. Eye (Lond), 35: 1418–1426. https://doi.org/10.1038/s41433-020-1024-8

[48]

Xu Y, Meng R, Rajah GB, et al., 2019, Long-term outcomes of cerebral venous sinus stenosis corrected by stenting. Curr Neurovasc Res, 16: 77–81. https://doi.org/10.2174/1567202616666190206185133

[49]

Li K, Ren M, Meng R, et al., 2019, Efficacy of stenting in patients with cerebral venous sinus thrombosis-related cerebral venous sinus stenosis. J Neurointerv Surg, 11: 307– 312. https://doi.org/10.1136/neurintsurg-2018–014328

Conflict of interest

The authors declare that they have no conflict of interest.

Previous article in this issue

Next article in this issue

Advanced Neurology, Electronic ISSN: 2810-9619 Published by AccScience Publishing